| Identification | Back Directory | [Name]
5-Quinoxalinecarbonitrile, 6-[[3-methoxy-4-[(6-methyl-3-pyridinyl)methoxy]phenyl]amino]-3-(4-morpholinyl)- | [CAS]
2222689-47-4 | [Synonyms]
5-Quinoxalinecarbonitrile, 6-[[3-methoxy-4-[(6-methyl-3-pyridinyl)methoxy]phenyl]amino]-3-(4-morpholinyl)- | [Molecular Formula]
C27H26N6O3 | [MOL File]
2222689-47-4.mol | [Molecular Weight]
482.53 |
| Chemical Properties | Back Directory | [Boiling point ]
703.2±60.0 °C(Predicted) | [density ]
1.35±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
5.28±0.10(Predicted) | [color ]
Light yellow to green yellow |
| Hazard Information | Back Directory | [Uses]
Enrupatinib is a colony-stimulating factor 1 receptor (CSF1R) inhibitor with antitumor activity[1]. | [References]
[1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 38, No. 2, 2024. |
|
|